SB 202190, CAS 152121-30-7

Description: SB 202190 (FHPI) is a p38 MAPK inhibitor that inhibits p38α and p38β2 (IC50=50/100 nM) selectively and cell-permeably. SB 202190 has antitumor activity and also induces the differentiation of human embryonic stem cells into cardiomyocytes.

CAS Number: 152121-30-7

Formula: C20H14FN3O

Molecular Weight: 331,34

References: Nassar K, et al. A p38 MAPK inhibitor improves outcome after glaucoma filtration surgery. J Glaucoma. 2015 Feb;24(2):165-78.

• SKU: TGMT2301-200mg
• Manufacturer: TargetMol Chemicals
• Manufacturer SKU: T2301-200mg
• Package Unit: 200 mg
• Quantity Unit: STK